...
首页> 外文期刊>U. S. pharmacist >Nonstimulant Agents for the Treatment of ADHD in Children
【24h】

Nonstimulant Agents for the Treatment of ADHD in Children

机译:非兴奋剂治疗儿童多动症

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurobehaviorai disorders of childhood. Stimulant medication is considered first- and second-line therapy for the management of ADHD. Although stimulants are very effective in controlling the symptoms of ADHD, they may cause serious adverse effects. Nonstimulant medications including atomoxetine, clonidine, guanfacine, tricyciic antidepressants, and bupropion offer an alternative to recommended therapy for treatment of ADHD. Pharmacists are essential in identifying potential drug-drug interactions and counseling caregivers and children about ADHD medications, including the potential adverse effects of, precautions for, and other expectations of these therapies.
机译:注意缺陷/多动障碍(ADHD)是儿童最常见的神经行为障碍之一。刺激性药物被认为是治疗多动症的一线和二线治疗方法。尽管兴奋剂在控制多动症的症状方面非常有效,但它们可能会引起严重的不良反应。包括阿莫西汀,可乐定,胍法辛,tricicciic抗抑郁药和安非他酮在内的非兴奋性药物可替代推荐的多动症治疗疗法。药剂师对于识别潜在的药物相互作用以及为看护者和儿童提供有关多动症药物的咨询至关重要,包括这些疗法的潜在不良反应,预防措施以及其他期望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号